June 9 (Reuters) – Privately held Element Biosciences said on Tuesday it had raised funds, including $175 million from longtime investor Samsung Electronics, to expand commercialisation of its genetic
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Coca-Cola lifts profit forecast as global soda demand holds firm
Oct 27 (Reuters) - Coca-Cola on Tuesday raised its annual profit forecast, betting on resilient…
GAMP Services Limited Files DRHP with SEBI for Proposed IPO
New Delhi [India], October 27: GAMP Services Limited, an integrated validation, qualification, compliance consulting and…
Osaka, Fernandez reach Pan Pacific last 16
VIDEO SHOWS: DAY TWO OF THE PAN PACIFIC OPEN - A WTA 500 TOURNAMENT IN…
